Skip to content

Comparison of the effect of triamcinolone acetonide and methyl prednisolone injection in shoulder Capsulitis treatment

Comparison of the effect of triamcinolone acetonide and methyl prednisolone injection in shoulder Capsulitis treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201109061106N5
Enrollment
100
Registered
2011-09-11
Start date
2010-09-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Capsulitis. Adhesive capsulitis of shoulder

Interventions

Intervention 1: In triamcinolone acetonide group : 40 mg triamcinolone in shoulder joint three times within 1 week is injected by a rheumatologist. Intervention 2: In Methyl Prednisolone group : 40 m
Treatment - Drugs
In triamcinolone acetonide group : 40 mg triamcinolone in shoulder joint three times within 1 week is injected by a rheumatologist
In Methyl Prednisolone group : 40 mg Methyl Prednisolone in shoulder joint three times within 1 week is injected by a rheumatologist

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria : patient with an acute (less than 2 weeks), subacute or chronic (more than 2 weeks), mechanical, contributed with nocturnal pain and loss of movement in glenohomural joint Exclusion criteria: patients who had intra-articular injections or oral steroids and physical therapy treatments received in the last 6 months,People who have had surgery, those with fracture or dislocation of the shoulder area, people with other diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before intervention, 1 and 4 weeks after intervention. Method of measurement: VAS.;Disability. Timepoint: Before intervention, 1 and 4 weeks after intervention. Method of measurement: SPADI(shoulder pain and disability index) questionarie.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.kamal Esalatmanesh

kashan Univercity of Medical Sciences

kamaleesalatmanesh@yahoo.com+98 36 1557 4415

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026